Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000403101 | SCV000345826 | uncertain significance | not provided | 2016-09-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001056380 | SCV001220821 | uncertain significance | Walker-Warburg congenital muscular dystrophy | 2022-06-27 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 438 of the FKTN protein (p.Arg438Cys). This variant is present in population databases (rs150852885, gnomAD 0.02%). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 31983221, 32746448). ClinVar contains an entry for this variant (Variation ID: 291125). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000403101 | SCV001771864 | uncertain significance | not provided | 2022-06-12 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Identified in patients with dilated cardiomyopathy (Mazzarotto et al., 2020; Burstein et al., 2021); This variant is associated with the following publications: (PMID: 31983221, 32746448) |
Mayo Clinic Laboratories, |
RCV000403101 | SCV002541007 | uncertain significance | not provided | 2021-05-12 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001056380 | SCV002081986 | uncertain significance | Walker-Warburg congenital muscular dystrophy | 2019-10-28 | no assertion criteria provided | clinical testing |